Literature DB >> 12420224

c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene.

Kou-Juey Wu1, Michela Mattioli, Herbert C Morse, Riccardo Dalla-Favera.   

Abstract

The c-MYC proto-oncogene encodes a ubiquitous transcription factor involved in the control of cell growth and differentiation and broadly implicated in tumorigenesis. Understanding the function of c-MYC and its role in cancer depends upon the identification of c-MYC target genes. Here we show that c-MYC induces the activity of Protein Kinase A (PKA), a key effector of cAMP-mediated signal transduction, by inducing the transcription of the gene encoding the PKA catalytic subunit beta (PKA-Cbeta). c-MYC-mediated induction of PKA-Cbeta gene transcription occurs in multiple tissues, is independent of cell proliferation and is mediated by direct binding of c-MYC to the PKA-Cbeta gene promoter sequences. Constitutive expression of PKA-Cbeta in Rat1A cells induces their transformation, and c-MYC-induced transformation can be reverted by pharmacological inhibition of PKA, suggesting that up-regulation of PKA is critical for c-MYC-associated tumorigenesis. These results indicate that, by activating PKA, c-MYC can provide endogenous activation of the cAMP signal transduction pathway independently of extracellular signals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420224     DOI: 10.1038/sj.onc.1205986

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors.

Authors:  Peter E Clark; Dina Polosukhina; Harold Love; Hernan Correa; Cheryl Coffin; Elizabeth J Perlman; Mark de Caestecker; Harold L Moses; Roy Zent
Journal:  Am J Pathol       Date:  2011-10-08       Impact factor: 4.307

2.  miR-17-92 and miR-106b-25 clusters regulate beta cell mitotic checkpoint and insulin secretion in mice.

Authors:  Amitai D Mandelbaum; Sharon Kredo-Russo; Danielle Aronowitz; Nadav Myers; Eran Yanowski; Agnes Klochendler; Avital Swisa; Yuval Dor; Eran Hornstein
Journal:  Diabetologia       Date:  2019-06-11       Impact factor: 10.122

3.  Phosphorylation of Par-4 by protein kinase A is critical for apoptosis.

Authors:  Sushma Gurumurthy; Anindya Goswami; Krishna Murthi Vasudevan; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  Targeting CREB Pathway Suppresses Small Cell Lung Cancer.

Authors:  Yifeng Xia; Cheng Zhan; Mingxiang Feng; Mathias Leblanc; Eugene Ke; Narayana Yeddula; Inder M Verma
Journal:  Mol Cancer Res       Date:  2018-03-09       Impact factor: 5.852

5.  Activating PRKACB somatic mutation in cortisol-producing adenomas.

Authors:  Stéphanie Espiard; Matthias J Knape; Kerstin Bathon; Guillaume Assié; Marthe Rizk-Rabin; Simon Faillot; Windy Luscap-Rondof; Daniel Abid; Laurence Guignat; Davide Calebiro; Friedrich W Herberg; Constantine A Stratakis; Jérôme Bertherat
Journal:  JCI Insight       Date:  2018-04-19

6.  Nonconventional involvement of LysRS in the molecular mechanism of USF2 transcriptional activity in FcepsilonRI-activated mast cells.

Authors:  Yu-Nee Lee; Ehud Razin
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.

Authors:  Charles J David; Mo Chen; Marcela Assanah; Peter Canoll; James L Manley
Journal:  Nature       Date:  2009-12-13       Impact factor: 49.962

8.  Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta.

Authors:  Shih-Hung Yu; Wei-Chung Chiang; Hsiu-Ming Shih; Kou-Juey Wu
Journal:  J Mol Med (Berl)       Date:  2004-06-09       Impact factor: 4.599

9.  MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.

Authors:  Martina Pigazzi; Elena Manara; Silvia Bresolin; Claudia Tregnago; Alessandra Beghin; Emma Baron; Emanuela Giarin; Er-Chieh Cho; Riccardo Masetti; Dinesh S Rao; Kathleen M Sakamoto; Giuseppe Basso
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

10.  Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

Authors:  Qinghai Liu; David H Nguyen; Qinghua Dong; Peter Shitaku; Kenneth Chung; On Ying Liu; Jonathan L Tso; Jason Y Liu; Veerauo Konkankit; Timothy F Cloughesy; Paul S Mischel; Timothy F Lane; Linda M Liau; Stanley F Nelson; Cho-Lea Tso
Journal:  J Neurooncol       Date:  2009-05-26       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.